Visby Medical, the at-home diagnostics company, today announced U.S. Food and Drug Administration (FDA) clearance for the ...
Over the past four years, many of us have become accustomed to a swab up the nose to test for COVID-19, using at-home rapid antigen tests or the more accurate clinic-provided PCR tests with a longer ...
The COVID-19 pandemic yielded important advances in testing for respiratory viruses, but it also exposed important unmet needs in screening to prevent the spread of infections in high-risk settings.
These tests have very limited clinical use. The need for antibody testing would be to determine if a patient has recovered from COVID-19, and whether we could take a sample of the patient’s plasma to ...
Because of its high accuracy, laboratory-based polymerase chain reaction (PCR) testing is the gold standard for infectious disease diagnostics. However, PCR technology requires highly trained staff ...
Key opportunities in the dye-free and label-free PCR packaging market include surging demand for precision genomic testing, ...
A new biotechnology company in McKinney has ambitions to become the world's first fully integrated platform for polymerase chain reaction (PCR) testing - the same technology behind a common COVID-19 ...
Real-time PCR enables faster Mycoplasma detection to meet rigorous cell therapy safety standards and reduce quality control-related workflow delays. Cell therapy innovation is accelerating, but ...
A new diagnostic tool developed by researchers can test for SARS-CoV-2 and Zika virus with the same or better accuracy as high-precision PCR tests in a matter of hours. Over the past four years, many ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results